Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone in Aneurysmal Subarachnoid Hemorrhage
NCT05131295Phase 3Completed
- Sponsor
- National Institute of Neurology and Neurosurgery
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aneurysmal subarachnoid hemorrhage (SAH) comparing Dapsone with Placebo (2 arms). Primary endpoint: Incidence of clinically defined delayed cerebral ischemia at 21 days. Started Sep 2007; status: completed.
02
Drugs
dapsone
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT05131295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05131295.